JAK 3i
JAK3i is a highly selective JAK3 inhibitor (IC50: 0.43 nM) . JAK3i forms a covalent bond with a cysteine in JAK3, but not the closely related kinase domains in JAK1, JAK2, or TYK2. JAK3i abolishes IL-2-driven T-cell proliferation in vivo and has the potential for autoimmune disease research[1].
Product Specifications
CAS Number
1918238-72-8
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jak-3i.html
Purity
99.81
Solubility
10 mM in DMSO
Smiles
CCOC(C1=CN=C2C1=C(C3=C(F)C=CC(NC(C=C)=O)=C3)NC=N2)=O
Molecular Formula
C18H15FN4O3
Molecular Weight
354.34
References & Citations
[1]Geoffrey A Smith, et al. Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling. Nat Chem Biol. 2016 May;12 (5) :373-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK1; JAK2; JAK3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Japanese Encephalitis Virus Envelope Protein Domain 3 (JEV E-D3) Antibody
Lentiviral human DIS3 shRNA (UAS) - Lentiviral human DIS3 shRNA (UAS, GFP) plasmid
Recombinant Acidovorax citrulli ATP synthase subunit b (atpF)
Amd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)